Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease
Crossref DOI link: https://doi.org/10.1007/s40259-014-0113-2
Published Online: 2014-12-11
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Garnock-Jones, K. P.
Text and Data Mining valid from 2014-12-11
